« June 8, 2008 | Main | June 22, 2008 »
June 11, 2008
3rd Annual Pharmacovigilance Conference
Location: London, England, UK
Dates: 11-13 June 2008
With increasing numbers of product recalls and market withdrawals, drug safety is something that can have a major impact on profitability. This, combined with the very real possibility of lawsuits, and raising the bar by various stakeholders, means that the field of pharmacovigilance is now under more pressure than ever before. If you’d like to know how to increase the safety of your portfolio, our lineup of expert speakers at Pharmacovigilance 2008 will be on hand to share their knowledge and experience.
Regulators are placing greater emphasis on post-approval surveillance, with the goalposts continually changing. Are you in a position to keep up?
Some of the key speakers include:
- Dr William Maier, Senior Director, Epidemiology, Elan
- Phillip Berry, Global Medical Director, Reckitt Benckiser
- John Parkinson, Group Head, General Practice Research Database
- William Gregory, Director, Safety and Risk Management, Pfi zer
- Georg Ferber, Group Head, Biostatistics, Novartis
- Christian Czech, CNS Research, Hoffmann–La Roche
- David J Lewis, Head of IMS PVO, Novartis
- Massimo Raineri, Head of System Development, Actelion
- Gurdyal Kalsi, Global Head, Medical and Regulatory Affairs, Global Clinical Development, MDS Pharma services
- Richard Thomas, Competency Development, CTG
Why should you attend? By attending this conference, you will find out what steps need to be taken in order to stay competitive and keep on the right side of the regulators. Furthermore, with several high-profile cases in the media, your company’s reputation could easily sustain significant damage unless your methods and practices are of the highest calibre. By implementing the optimal strategy now, you can reduce the cost and time spent on using other more traditional methods. And with the field of drug discovery now experiencing impressive advancements through technologies, those at the forefront will lead the way in this profitable sector. Are you in order to make the promised gains? Listen to the presentations from our panel of industry leaders at this event to see what you can do make the best use of data processing, and forge the right partnerships for the coming years. Only one conference this year will allow you to strike the right balance between risk and benefit, and to make the right decisions.
We invite you to book now to avoid missing out on what promises to be a unique exchange of knowledge and ideas.
Who Should Attend?
- Head of Pharmacovigilance Strategy
- Director of Drug Safety/Risk Management
- Head of Information and Clinical Data Management
- VP/Head of Clinical Research
- Head of Research & Development and Product Safety/Assurance Assessment
- VP/Head of Patient Safety and Outcomes Research and Data Analysis
- Head of Epidemiology Project Management
- VP/Head of Regulatory Affairs and Compliance VP of Sales & Marketing
Registering: All you need to book your place is either email Jacob at pharma.conferences1@conferencesandreports.com or call on TEL: +44 (0)207 549 9971.
